ロード中...
The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis
BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...
保存先:
| 出版年: | Syst Rev |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4351824/ https://ncbi.nlm.nih.gov/pubmed/25874839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0001-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|